• Archives of Plastic Surgery
• /
• 제38권2호
• /
• pp.207-211
• /
• 2011

Purpose: Surgery for thyroid gland requires skin incisions that can result in postsurgical neck scar. To overcome this, many surgeons performed a endoscopic thyroidectomy. But, this approach had a some problems. One of postoperative problems, iatrogenic cervical dystonia (CD) may occur. At common, CD is defined as a syndrome characterized by prolonged muscle contraction causing twisting, repetitive movements or abnormal posture. Botulinum toxin A (BTA, Botox$^{(R)}$, Allergan, Irvine, CA, USA) is well known treatment agent in the treatment of CD. So, the authors applied BTA injection in rare case with iatrogenic CD resulting in endoscopic thyroidectomy. Methods: A 43-year-old female had endoscopic subtotal thyroidectomy operation 3 years ago. She had symptoms such as progressive cervical pain, abnormal neck posture, depression, and sleep difficulty. About 1 year later, the patient who had previous myomectomy of the clavicular head of sternocleidomastoid muscle, however, symptoms were not improved. And then the patient received BTA therapy in our department. The 2 units per 0.1 mL solution was administered in a 1 mL tuberculin syringe. Results: The dose of BTA used in the patient was 36 units for vertical platysmal bands, superficially, and 10 units for ipsilateral sternocleidomastoid muscle, intramuscularly. After 2 weeks, additional the dose of BTA used in the patient was 5 points for remained scar bands, superficially. Complications related to injection such as significant swallowing difficulties, neck muscle weakness, or sensory change were not observed. In 9 months follow-up, the patient maintained a good result from the method of BTA injection alone. Conclusion: The basic concept is selective denervation for the hyperactive individual muscles and scar bands. We conclude that BTA is an effective and safe treatment for CD despite the iatrogenic and complex presentation of this complication.

• Journal of Pharmaceutical Investigation
• /
• 제30권1호
• /
• pp.61-65
• /
• 2000

Doxazosin, a postsynaptic selective ${\alpha}1-adrenoceptor$ antagonist, is a potent antihypertensive agent which reduces peripheral resistance and blood pressure by vasodilatation of peripheral vessels. It is also used in the treatment of urinary obstruction by benign prostatic hypertrophy. The purpose of the present study was to evaluate the bioequivalence of two doxazosin tablets, $Cardura^{TM}$ (Pfizer Korea Ltd.) and $Cardil^{TM};$ (Kyungdong Pharmaceutical Co., Ltd.), according to the guidelines of Korea Food and Drug Administration (KFDA). Sixteen normal male volunteers, $24.19{\pm}2.48$ years in age and $62.41{\pm}6.66$ kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After one tablet containing 2 mg of doxazosin was orally administered, blood was taken at predetermined time intervals and the concentrations of doxazosin in serum were determined with an HPLC method using spectrofluorometric detector. Pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two tablets were -1.54%, -1.51 % and 3.42%, respectively, when calculated against the $Cardura^{TM}$ tablet. The powers $(1-{\beta})$ for $AUC_t,\;C_{max}\;and\;T_{max}$ were all more than 99.00%. Minimum detectable differences $(\Delta)$ at ${\alpha}=0.05\;and\;1-{\beta}=0.8$ were all less than 20% (e.g., 12.73%, 12.84% and 13.01% for $AUC_t,\;C_{max}\;and\;T_{max}$, respectively). The 90% confidence intervals were all within :${\pm}20%$ (e.g., $-8.97{\sim}5.90,\;-9.01{\sim}6.00\;and\;-4.16{\sim}11.05\;for\;AUC_t,\;C_{max}\;and\;T_{max},\;respectively)$. All of the above para- meters met the criteria of KFDA for bioequivalence, indicating that $Cardil^{TM}$ tablet is bioequivalent to $Cardura^{TM}$ tablet.

• Bulletin of the Korean Chemical Society
• /
• 제29권7호
• /
• pp.1303-1310
• /
• 2008

Inhibitors of farnesyltransferase (FT), a key enzyme in the post-translational modifications of Ras proteins, have been extensively studied as novel anticancer agents in the preclinical stages, some of which are currently in clinical development. Previously, it has been reported that a novel FT inhibitor LB42907 inhibits Ras farnesylation in the nanomolar range in vitro. The aim of this study was to assess the antitumor efficacy of LB42907 in vitro and in vivo. Anchorage-independent growth of various human tumor cell lines was potently inhibited by treatment with LB42907, comparable to other FT inhibitors in clinical development. In the nude mouse, oral administration of LB42907 demonstrated potent antitumor activity in several human tumor xenograft models including bladder, lung and pancreas origin. Interestingly, significant tumor regression in EJ (bladder) and A549 (lung) xenografts was induced by LB42907 treatment. The effectiveness of LB42907 was also investigated in simultaneous combination with paclitaxel, vincristine, cisplatin or gemcitabine against NCI-H460, A549, and HCT116 cells in vitro using median-effect analysis. LB42907 markedly synergized with most anticancer drugs tested in this study in NCI-H460 cell. In contrast, LB42907 displayed antagonism or partial synergism with these drugs in A549 and HCT116 cells, depending on the class of combined drugs and/ or the level of cytotoxicity. Our results demonstrate that LB42907 is an effective antitumor agent in vitro and in vivo and combination of LB42907 with other chemotherapeutic drugs results in synergistic or antagonistic effects mainly in a cell line-dependent manner. Further preclinical study is warranted.

• 한국지반신소재학회논문집
• /
• 제19권1호
• /
• pp.25-33
• /
• 2020

본 연구에서는 기존 차수재가 수분과의 팽윤성을 갖는 특징을 개선하기 위해 모래, 칼슘-벤토나이트 및 겔화제 혼합물의 트리클로로에틸렌(TCE) 반응에 따른 투수 특성을 평가하였다. 이를 위해 연구 재료의 기본적인 특성 분석, 투수시험을 진행하였다. 투수계수는 칼슘-벤토나이트 혼합 비율이 증가함에 따라 감소하였으며, 겔화제 혼합 비율이 증가함에 따라 증가하였다. 결론적으로, 칼슘-벤토나이트 15%, 겔화제 30% 이상 혼합 시 지하수 유동에서의 투수계수는 α × 10^-4 cm/sec 이상으로 분석되어 지하수 유동을 차단하지 않는 것으로 분석되었다. 또한 TCE 반응 시 혼합차수물의 투수계수는 α × 10^-7 cm/sec 이하로 분석되어, 차단층 투수계수 조건(1.0 × 10^-6 cm/sec 미만)을 만족하였다. 따라서 칼슘-벤토나이트와 겔화제는 TCE로 오염된 토양 및 지하수에 선택적 투수능 변환 특성을 보이는 차수재로서 활용이 가능하다.

• KSBB Journal
• /
• 제25권6호
• /
• pp.527-532
• /
• 2010

A thiazolidinedione derivative, TD49 with the highly selective algicide to red tide was newly synthesized and its acute toxicity was examined in order to evaluate the effect on aquatic ecosystems of coast. Major three species having important role in the food chain of marine ecosystem, such as Skeletonema costatum of microalgae, Daphnia magna of crustacea, Paralichthys olivaceus of flatfish fingerling were employed for the acute toxicity assessment. $EC_50$ or $LC_50$ as the assessment criterion was investigated to each specie, and NOEC (No Observed Effect Concentration) and PNEC (Predicted No Effect Concentration) from most sensitive specie to toxicity of TD49 were further calculated. $EC_50$ of S. costatum in 96-hour, $EC_50$ of D. magna in 48-hour, and $LC_50$ of P. olivaceus in 72-hour for TD49 were $0.34\;{\mu}M$, $0.68\;{\mu}M$, and $0.58\;{\mu}M$, respectively. NOEC from the results of S. costatum was estimated to be $0.20\;{\mu}M$ and PNEC was estimated as 3.40 nM by applying factor value of 100 to $EC_50$ $0.34\;{\mu}M$ of S. costatum. In addition, it was revealed that Solutol used as the dispersing agent of TD49 had very little toxic influence under the concentration range of $0{\sim}0.4\;{\mu}M$ used in TD49 toxicity experiment. Although the estimated concentration of TD49 that will be sprayed onto the coastal field for the algicide is higher than NOEC value, it is considered that the spraying concentration would not be a considerable problem due to a dilution effect by tide at the opened coast.

• 분석과학
• /
• 제17권6호
• /
• pp.454-463
• /
• 2004

XAD-16-Chromotropic acid (CTA)형 킬레이트 수지에 대한 몇 가지 금속이온의 흡착특성을 뱃치법과 용리법으로 조사하였다. pH 변화에 따른 금속 이온의 흡착율을 조사한 결과 pH 3.0 ~ 6.0에서 Hf(IV), Zr(IV), Th(IV) 이온이 다른 금속 이온들에 비해 높은 선택성을 보였으며, Zr(IV)의 최대흡착용량은 0.81 mmol/g이었다. 가리움제로서 CDTA, EDTA, NTA 및 $NH_4F$ 등을 사용하여 흡착에 미치는 영향을 조사한 결과 혼합 금속 용액으로부터 몇 가지 희토류 금속 이온들의 분리가 가능함을 알 수 있었다. 킬레이트 수지에 대한 몇 가지 금속 이온들의 흡착거동을 용리법으로 조사 검토한 결과 pH 4에서 돌파점 용량과 총괄 용량으로부터 얻은 금속 이온의 용리 순서는 Zr(IV)>Th(IV)>Hf(IV)>U(VI)>Cu(II)>In(III)>Pb(II) 이었다. 한편 HCl, $HNO_3$, $HClO_4$ 등의 탈착제에 의한 탈착 특성을 조사한 결과 2 M HCl에서 높은 탈착효율을 나타내었다. XAD-16-CTA 킬레이트 수지는 혼합 금속이온 중에 함유된 Th(IV) 이온의 선택적 분리 및 회수에 유용함을 알 수 있었다.

• 생명과학회지
• /
• 제23권11호
• /
• pp.1342-1350
• /
• 2013

본 연구는 화학적 허혈에 의해 손상된 마우스 간세포에서 hydrogen sulfide ($H_2S$)의 효과를 규명하기 위해 수행되었다. 본 연구에서 허혈 모방 화합물로 알려져 있는 cobalt chloride ($CoCl_2$)는 간세포 손상을 시간 및 농도 의존적으로 유의성 있게 증가 시켰다. $CoCl_2$에 의한 간세포 손상은 Sodium sulfide (NaHS, $H_2S$ 공여제)의 전처리에 의해 유의적으로 감소 되었다. $CoCl_2$는 세포 내 활성산소(reactive oxygen species, ROS)의 농도를 증가시켰으며, 이는 NaHS 및 N-acetyl-cysteine (NAC, a ROS 제거제)에 의해 감소하였다. 또한, $CoCl_2$에 의해 증가된 p38 MAPK 인산화가 NaHS 및 NAC에 의해 억제되었다. $CoCl_2$에 의해 증가된 Bax/Bcl-2 비율은 NaHS, NAC 및 SB 203580 (p38 MAPK 저해제)에 의해 차단되었으며, $CoCl_2$에 의해 유발된 간세포의 손상 또한 NaHS, NAC 및 SB 203580의 전처리에 의해 억제되었다. NaHS는 $CoCl_2$에 의해 증가된 COX-2의 발현을 억제하였다. 또한, NaHS의 효과와 유사하게 $CoCl_2$에 의해 증가된 COX-2의 발현이 NAC에 의해 억제되었다. 더욱이, NS-398 (COX-2 선택적 억제제)는 $CoCl_2$에 의한 Bax/Bcl-2 비율의 증가를 억제하였을 뿐 아니라, 간세포의 세포 손상 또한 억제하였다. 결론적으로, $H_2S$는 초대배양 된 마우스 간세포에서 $CoCl_2$에 의해 유발된 간세포의 손상을 ROS에 의해 유발된 p38 MAPK 및 COX-2 경로의 활성화를 억제함으로써 세포보호효과를 수행하는 것을 알 수 있었다.

• 약학회지
• /
• 제52권3호
• /
• pp.188-194
• /
• 2008

Fexofenadine, ($\pm$)-4-1-hydroxy-4-{4-(hydroxydiphenylmethyl)-1-piperidinyl}-butyl-a,a-dimethyl benzeneacetic acid, is a selective histamine $H_1$ receptor antagonist, and is clinically effective in the treatment of seasonal allergic rhinitis and chronic idiopathic urticaria as a first-line therapeutic agent. The purpose of the present study was to evaluate the bioequivalence of two fexofenadine hydrochloride tablets, $Allegra^{(R)}$ (Handok Pharmaceuticals Co., Ltd.) and Alecort (Samchundang Pharmaceutical Co., Ltd.), according to the guidelines of the Korea Food and Drug Administration (KFDA). The release of fexofenadine from the two fexofenadine hydrochloride formulations in vitro was tested using KP VIII Apparatus II method with various dissolution media. Twenty six healthy male subjects, 25.62$\pm$3.35 years in age and 70.05$\pm$11.71 kg in body weight, were divided into two groups and a randomized 2$\times$2 cross-over study was employed. After a single tablet containing 120 mg as fexofenadine hydrochloride was orally administered, blood samples were taken at predetermined time intervals and the concentrations of fexofenadine in serum were determined using HPLC with fluorescence detector. The dissolution profiles of two formulations were similar in all tested dissolution media. The harmacokinetic parameters such as $AUC_t$, $C_{max}$ and $T_{max}$ were calculated, and ANOVA test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t$, $C_{max}$ and untransformed $T_{max}$. The results showed that the differences between two formulations based on the reference drug, $Allegra^{(R)}$, were -1.37, 5.22 and 16.50% for $AUC_t$, $C_{max}$ and $T_{max}$, respectively. There were no sequence effects between two formulations in these parameters. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log 0.8 to log 1.25 (e.g., log 0.83$\sim$log 1.08 and log 0.81$\sim$log 1.03 for $AUC_t$ and $C_{max}$, respectively). Thus, the criteria of the KFDA bioequivalence guideline were satisfied, indicating Alecort tablet was bioequivalent to $Allegra^{(R)}$ tablet.

• 공업화학
• /
• 제32권6호
• /
• pp.599-606
• /
• 2021

본 연구는 질소산화물 제거를 위하여 암모니아를 환원제로 사용하는 선택적 촉매 환원법에 있어 지지체에 셀레늄을 첨가하여 300 ℃ 이하에서 V₂O₅/WO₃/TiO₂의 반응 활성을 증진시키기 위한 실험 및 반응특성 연구를 수행하였다. 졸-겔법으로 Se-TiO₂ 및 TiO₂를 합성하였으며, 이를 지지체로 하여 V₂O₅/WO₃/TiO₂ 및 V₂O₅/WO₃/Se-TiO₂ 촉매를 제조하여 상용 촉매와 반응 활성을 비교하였다. 실험 결과, 졸-겔법으로 합성한 TiO₂를 사용한 촉매의 탈질 효율이 상용 TiO₂를 사용하여 제조한 촉매보다 낮은 결과를 보였으나 셀레늄을 첨가함에 따라 탈질 효율이 증진되었다. 따라서 BET, XRD, Raman, H₂-TPR 및 FT-IR분석을 통하여 셀레늄의 첨가가 촉매의 구조에 미치는 영향을 분석하였으며 셀레늄 첨가에 의한 비표면적의 증가와 단량체 및 복합체 바나듐 종의 형성이 반응 특성에 미치는 영향을 확인하였다.

• 한국수산과학회지
• /
• 제52권5호
• /
• pp.461-467
• /
• 2019

Several studies investigating the prevention and treatment of external parasites in farmed olive flounder Paralichthys olivaceus have found that the anticoccidial agent toltrazuril sulfone is an effective antiparasitic. Prior to undertaking a full-scale study, we developed analytical methods to detect the levels of toltrazuril and toltrazuril sulfone in farmed flounder samples using liquid chromatography-electrospray ionization tandem mass spectrometry (LC-MS/MS). This analysis showed that LC-MS/MS changed the mobile phase and collision energy of toltrazuril and toltrazuril sulfone. This was validated using established conditions. Sample pre-treatment for this process involved extraction with dichloromethane and purification by liquid-liquid extraction in formic acid, acetonitrile, and h-hexane, followed by determination of all compounds by LC-MS/MS. Separation was achieved within 10 min by gradient elution using a Capcell Pak C18 ($3.0{\mu}m$, $100{\times}2.0mm$) analytical column (Shiseido UG 120V) with a mixture of 0.1% (v/v) formic acid and acetonitrile. Multiple reaction monitoring was used for selective detection of toltrazuril and toltrazuril sulfone. This method yields satisfactory results for linearity, precision, and limits of quantification. Therefore, the method established in our study will serve as a basis for further research on parasite control by toltrazuril and toltrazuril sulfone.